ACTIVE_NOT_RECRUITING

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

Official Title

A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma

Quick Facts

Study Start:2016-12
Study Completion:2027-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT02954094

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male or female patients, age ≥18 years
  2. 2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Locations (Sites)

Banner University Medical Center
Phoenix, Arizona, 85006
United States
University of Arkansas
Little Rock, Arkansas, 72205
United States
University of Southern California/Norris Comprehensive Cancer Center
Los Angeles, California, 90033
United States
Stanford University
Palo Alto, California, 94304
United States
California Liver Research Institute
Pasadena, California, 91105
United States
University of California-Davis
Sacramento, California, 95817
United States
University of California
San Francisco, California, 94158
United States
Georgetown University
Washington D.C., District of Columbia, 20007
United States
Gastro Florida
Clearwater, Florida, 33762
United States
University of Florida Hepatology Research at CTRB
Gainesville, Florida, 32610-0272
United States
University of Florida Health Gastroenterology
Jacksonville, Florida, 32207
United States
Schiff Center for Liver Diseases/University of Miami
Miami, Florida, 33136
United States
Tampa General Medical Group
Tampa, Florida, 33606
United States
Piedmont Atlanta Hospital
Atlanta, Georgia, 30309
United States
Piedmont Cancer Institute
Atlanta, Georgia, 30318
United States
Emory University Hospital
Atlanta, Georgia, 30322
United States
Northwestern University Division of Gastroenterology and Hepatology
Chicago, Illinois, 60611
United States
Rush University Medical Center
Chicago, Illinois, 60612
United States
University of Chicago
Chicago, Illinois, 60637
United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242
United States
Tulane University
New Orleans, Louisiana, 70112
United States
Mercy Medical Center, GI Research
Baltimore, Maryland, 21202
United States
Johns Hopkins University
Baltimore, Maryland, 21205
United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215
United States
University of Michigan
Ann Arbor, Michigan, 48109
United States
Henry Ford Health System
Detroit, Michigan, 48202
United States
Mayo Clinic
Rochester, Minnesota, 55905
United States
Southern Therapy and Advanced Research (STAR) LLC
Jackson, Mississippi, 39216
United States
Saint Louis University
St Louis, Missouri, 63110
United States
University of Nebraska Medical Center
Omaha, Nebraska, 68106
United States
Rutgers-Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08901
United States
Northwell Health - Center for Liver Diseases
Manhasset, New York, 11030
United States
NYU Langone Health
New York, New York, 10016
United States
Weill Cornell Medical College
New York, New York, 10021
United States
Columbia University
New York, New York, 10032
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
United States
Center for Liver Disease and Transplant at CMC
Charlotte, North Carolina, 28204
United States
Providence Health & Services Cancer Clinical Trials
Portland, Oregon, 97213
United States
Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033
United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States
Medical University of South Carolina
Charleston, South Carolina, 29403
United States
Vanderbilt University Medical Center - GI Research Office
Nashville, Tennessee, 37212
United States
Clinical Research Institute@ Methodist Dallas Medical Center
Dallas, Texas, 75203
United States
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-8887
United States
Baylor Scott & White All Saints
Fort Worth, Texas, 76104
United States
Research Specialists of Texas
Houston, Texas, 77030
United States
University of Virginia
Charlottesville, Virginia, 22908
United States
Bon Secours Liver Institute of Virginia
Richmond, Virginia, 23226
United States
Virginia Commonwealth University
Richmond, Virginia, 23298
United States
Harborview Medical Center
Seattle, Washington, 98104
United States
Wenatchee Valley Hospital & Clinics
Wenatchee, Washington, 98801
United States
University of Wisconsin
Madison, Wisconsin, 53705-2281
United States

Collaborators and Investigators

Sponsor: Target PharmaSolutions, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-12
Study Completion Date2027-02

Study Record Updates

Study Start Date2016-12
Study Completion Date2027-02

Terms related to this study

Additional Relevant MeSH Terms

  • Hepatocellular Cancer